Allspring Global Investments Holdings LLC increased its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 56 ...

Investors in Becton Dickinson and Company BDX, popularly known as BD, need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $120.00 ...

Blue Trust Inc. reduced its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 42.9% in the 4th quarter, ...

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...

Headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company (BDX) is a global leader in medical technology ...

GlobalData’s director of therapy research & analysis in medical devices says the new entity could make an attractive ...

Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic solutions arms to become ...

Reports Q1 revenue $5.2B, consensus $5.11B. “We delivered strong operational performance in Q1, with revenue growth, margin expansion and ...

BDX's overall topline in the first quarter of fiscal 2025 continues to benefit from revenue growth in all segments.